(Q43522193)

24 November 2017

title

Immunity against measles in populations of women and infants in Poland (English)

1 reference

24 November 2017

1 reference

1 reference

2

Janusz Slusarczyk

1 reference

24 November 2017

Wieslawa Janaszek

1

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

24 November 2017

1 reference

24 November 2017

volume

21

1 reference

24 November 2017

issue

21-22

1 reference

24 November 2017

page(s)

2948-2953

1 reference

Excess mortality after early exposure to measles

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Further-attenuated measles vaccine: characteristics and use.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Reduced measles immunity in infants in a well-vaccinated population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Measles vaccination of infants in a well-vaccinated population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Passive immunity against measles during the first 8 months of life of infants born to vaccinated mothers or to mothers who sustained measles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Measles virus specific antibody in infants in a highly vaccinated society

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Maternal measles antibody decay in rural Bangladeshi infants--implications for vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Increased susceptibility to measles in infants in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Immunology taught by viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Immune response to measles vaccine in 6-month-old infants of measles seronegative mothers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

The epidemiology of measles in Poland: prevalence of measles virus antibodies in the population

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

Measles vaccine efficacy during an outbreak in a highly vaccinated population: Incremental increase in protection with age at vaccination up to 18 months

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900113-0

7 January 2021

10.1016/S0264-410X(03)00113-0

Identifiers

DOI

1 reference

24 November 2017

1 reference